6177 results
Cited 54 times since 2008 (3.1 per year)
source: EuropePMC
The American journal of cardiology,
Volume 101, Issue 7, 6 1 2008, Pages 1023-1029
Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
Van de Veire NR, Marsan NA, Schuijf JD, Bleeker GB, Wijffels MC, van Erven L, Holman ER, De Sutter J, van der Wall EE, Schalij MJ, Bax JJ
Objectives of this study were to perform a prospective head-to-head comparison between multi-slice computed tomography (MSCT) venography and invasive venography in cardiac resynchronization therapy (CRT) candidates as well as to evaluate the relation between left ventricular (LV) lead position and effect on LV dyssynchrony and immediate response to CRT. Twenty-one consecutive heart failure patients scheduled for CRT implantation were prospectively enrolled to undergo 64-slice MSCT to visualize t...
Abstract
Cited 94 times since 2008 (5.5 per year)
source: EuropePMC
Journal of the American College of Cardiology,
Volume 51, Issue 6, 1 1 2008, Pages 618-626
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.
van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ
Objectives: Our purpose was to evaluate the efficacy and safety of drug-eluting stents in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI). Background: There is inconsistent and limited evidence about the efficacy and safety of drug-eluting stents in STEMI patients. Methods: A single-blind, single-center, randomized study was performed to compare bare-metal stents (BMS) with sirolimus-eluting stents (SES) in 310 STEMI patients. The...
Abstract
Cited 55 times since 2008 (3.2 per year)
source: EuropePMC
The Journal of cardiovascular surgery,
Volume 49, Issue 1, 1 1 2008, Pages 51-58
Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.
Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, Van Bockel JH, Lindeman JH
Aim: Recent evidence indicates that bone marrow mononuclear cells (BMC) promote collateral vessel formation in patients with severe peripheral arterial disease (PAD). However, aspects concerning optimal administration mode, durability and long-term safety require consideration. Combined intra-arterial (IA) plus intramuscular (IM) BMC delivery may be more effective than exclusive intramuscular injections. The aim of this study was to evaluate feasibility, safety and effect of exclusive IM versus...
Abstract
Cited 2 times since 2008 (0.1 per year)
source: EuropePMC
Clinical nuclear medicine,
Volume 33, Issue 2, 1 1 2008, Pages 89-93
Myocardial perfusion scintigraphy with adenosine: does it impair the left ventricular ejection fraction obtained with gated SPECT?
Brinkman N, Dibbets-Schneider P, Scholte AJ, Stokkel MP
Background: The aim of this study was to assess whether adenosine impairs left ventricular ejection fraction (LVEF) obtained with gated SPECT in patients with a normal myocardial perfusion scintigram. Materials and methods: This prospective study included 160 consecutive patients with a normal myocardial perfusion scintigraphy (MPS), who were stressed with either exercise (n = 64) or with adenosine (n = 96). Student t-test or chi test was used to compare patient's characteristics and functi...
Abstract
Cited 50 times since 2008 (2.9 per year)
source: EuropePMC
International journal of cardiology,
Volume 132, Issue 2, 1 1 2008, Pages 257-262
Coronary collaterals improve prognosis in patients with ischemic heart disease.
Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, van der Graaf Y, Doevendans PA
Background: The recruitment of coronary collateral vessels results from an endogenous adaptation to ischemic heart disease (IHD). Presence of collaterals may exert protection at the time of acute or chronic obstructive coronary disease. The protective role of collaterals in patients with extensive coronary artery disease however, has been disputed. We examined the effects of coronary collateral circulation on cardiovascular outcomes, with an emphasis on clinical prognostic value and on a putativ...
Abstract
Cited 20 times since 2008 (1.2 per year)
source: EuropePMC
Journal of anatomy,
Volume 212, Issue 3, 1 1 2008, Pages 286-294
Chronic right ventricular pressure overload results in a hyperplastic rather than a hypertrophic myocardial response.
Leeuwenburgh BP, Helbing WA, Wenink AC, Steendijk P, de Jong R, Dreef EJ, Gittenberger-de Groot AC, Baan J, van der Laarse A
Myocardial hyperplasia is generally considered to occur only during fetal development. However, recent evidence suggests that this type of response may also be triggered by cardiac overload after birth. In congenital heart disease, loading conditions are frequently abnormal, thereby affecting ventricular function. We hypothesized that chronic right ventricular pressure overload imposed on neonatal hearts initiates a hyperplastic response in the right ventricular myocardium. To test this, young l...
Abstract
Cited 15 times since 2008 (0.9 per year)
source: EuropePMC
Current medical research and opinion,
Volume 24, Issue 2, 1 1 2008, Pages 359-364
ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
Liem AH, van de Woestijne AP, Roeters van Lennep HW, Zwinderman AH, van der Steeg WA, Jukema JW
Background: It is generally accepted that low density lipoprotein cholesterol (LDL-C) or calculated ratios such as LDL-C to high density lipoprotein cholesterol (HDL-C) (LDL-C/HDL-C) are useful predictors of risk of cardiovascular disease in the primary as well as in the secondary prevention setting. However, there is accumulating evidence that the ratio of the corresponding apolipoproteins (apoB/A1) might be superior in some populations. Little is known with regard to the prognostic significanc...
Abstract
Cited 170 times since 2008 (9.9 per year)
source: EuropePMC
The Annals of thoracic surgery,
Volume 85, Issue 2, 1 1 2008, Pages 430-6; discussion 436-7
Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure.
Braun J, van de Veire NR, Klautz RJ, Versteegh MI, Holman ER, Westenberg JJ, Boersma E, van der Wall EE, Bax JJ, Dion RA
Background: Restrictive mitral annuloplasty with revascularization is considered the best approach to ischemic mitral regurgitation with heart failure, but late results are controversial. We report late outcome in relation to preoperative left ventricular end-diastolic diameter (LVEDD) cutoff values, previously identified to predict intermediate-term left ventricular reverse remodeling. Methods: One hundred consecutive ischemic mitral regurgitation patients underwent restrictive mitral annulopla...
Abstract
Cited 10 times since 2008 (0.6 per year)
source: EuropePMC
European heart journal,
Volume 29, Issue 3, 1 1 2008, Pages 283-284
Preoperative cardiac risk assessment in vascular surgery patients: seeing beyond the perioperative period.
Schouten O, Bax JJ, Poldermans D
Abstract
Cited 75 times since 2008 (4.3 per year)
source: EuropePMC
Proceedings of the National Academy of Sciences of the United States of America,
Volume 105, Issue 5, 30 5 2008, Pages 1692-1697
Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins.
Thomae AW, Pich D, Brocher J, Spindler MP, Berens C, Hock R, Hammerschmidt W, Schepers A
In all eukaryotic cells, origins of DNA replication are characterized by the binding of the origin recognition complex (ORC). How ORC is positioned to sites where replication initiates is unknown, because metazoan ORC binds DNA without apparent sequence specificity. Thus, additional factors might be involved in ORC positioning. Our experiments indicate that a family member of the high-mobility group proteins, HMGA1a, can specifically target ORC to DNA. Coimmunoprecipitations and imaging studies...
Abstract
Cited 46 times since 2008 (2.7 per year)
source: EuropePMC
Journal of affective disorders,
Volume 110, Issue 1-2, 30 5 2008, Pages 27-35
Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors.
Smolderen KG, Aquarius AE, de Vries J, Smith OR, Hamming JF, Denollet J
Background: Depressive symptoms are associated with poor prognosis in coronary artery disease, but there is a paucity of research on these symptoms in peripheral arterial disease (PAD). We examined the clinical correlates and 18-month course of depressive symptoms in PAD patients. Methods: 166 patients with symptomatic lower-extremity PAD (39% women; M age=64.9 +/- 10 years) completed the 10-item Center for Epidemiological Studies Depression scale. A score > or =4 indicates clinically relevan...
Abstract
Cited 50 times since 2008 (2.9 per year)
source: EuropePMC
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Volume 21, Issue 7, 28 4 2008, Pages 801-807
Real-time three-dimensional echocardiography as a novel approach to quantify left ventricular dyssynchrony: a comparison study with phase analysis of gated myocardial perfusion single photon emission computed tomography.
Marsan NA, Henneman MM, Chen J, Ypenburg C, Dibbets P, Ghio S, Bleeker GB, Stokkel MP, van der Wall EE, Tavazzi L, Garcia EV, Bax JJ
Background: Different imaging modalities have been explored for assessment of left ventricular (LV) dyssynchrony. Gated myocardial perfusion single photon emission computed tomography (GMPS) with phase analysis is a reliable technique to quantify LV dyssynchrony and predict response to cardiac resynchronization therapy. Objective: Real-time 3-dimensional echocardiography (RT3DE) is a novel imaging technique that provides a LV systolic dyssynchrony index, based on regional volumetric changes as a...
Abstract
Cited 29 times since 2008 (1.7 per year)
source: EuropePMC
Current medical research and opinion,
Volume 24, Issue 3, 25 4 2008, Pages 685-694
The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW
Objective: To assess the incremental low-density lipoprotein-cholesterol (LDL-C) lowering efficacy of doubling the statin dose or switching to the ezetimibe/simvastatin 10/20 mg combination tablet (EZE/SIMVA) in patients on simvastatin 20 mg or atorvastatin 10 mg not at LDL-C target < 2.5 mmol/L. Study design and methods: Patients with documented coronary heart disease (CHD) and/or type 2 diabetes (DM2) with LDL-C > or = 2.5 and < 5.0 mmol/L despite treatment with atorvastatin 10 mg or...
Abstract
Cited 8 times since 2008 (0.5 per year)
source: EuropePMC
BMC genetics,
Volume 9, 25 4 2008, Pages 9
Estimating effects of rare haplotypes on failure time using a penalized Cox proportional hazards regression model.
Souverein OW, Zwinderman AH, Jukema JW, Tanck MW
Background: This paper describes a likelihood approach to model the relation between failure time and haplotypes in studies with unrelated individuals where haplotype phase is unknown, while dealing with the problem of unstable estimates due to rare haplotypes by considering a penalized log-likelihood. Results: The Cox model presented here incorporates the uncertainty related to the unknown phase of multiple heterozygous individuals as weights. Estimation is performed with an EM algorithm. In th...
Abstract
Cited 2 times since 2008 (0.1 per year)
source: EuropePMC
European journal of nuclear medicine and molecular imaging,
Volume 35, Issue 3, 22 4 2008, Pages 532-534
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
Bax JJ, Boogers M, Henneman MM
Abstract
Cited 45 times since 2008 (2.6 per year)
source: EuropePMC
Stem cells (Dayton, Ohio),
Volume 26, Issue 4, 17 3 2008, Pages 1083-1093
Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.
Grauss RW, van Tuyn J, Steendijk P, Winter EM, Pijnappels DA, Hogers B, Gittenberger-De Groot AC, van der Geest R, van der Laarse A, de Vries AA, Schalij MJ, Atsma DE
Human mesenchymal stem cells (hMSCs) have only a limited differentiation potential toward cardiomyocytes. Forced expression of the cardiomyogenic transcription factor myocardin may stimulate hMSCs to acquire a cardiomyogenic phenotype, thereby improving their possible therapeutic potential. hMSCs were transduced with green fluorescent protein (GFP) and myocardin (hMSC(myoc)) or GFP and empty vector (hMSC). After coronary ligation in immune-compromised NOD/scid mice, hMSC(myoc) (n = 10), hMSC (n...
Abstract
Cited 72 times since 2008 (4.2 per year)
source: EuropePMC
European heart journal,
Volume 29, Issue 4, 17 3 2008, Pages 557-563
Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement.
Marcassa C, Bax JJ, Bengel F, Hesse B, Petersen CL, Reyes E, Underwood R, European Council of Nuclear Cardiology (ECNC), European Society of Cardiology Working Group 5 (Nuclear Cardiology and Cardiac CT), European Association of Nuclear Medicine Cardiovascular Committee
Mortality rates due to coronary artery disease (CAD) have declined in recent years as result of improved prevention, diagnosis, and management. Nonetheless, CAD remains the leading cause of death worldwide with most casualties expected to occur in developing nations. Myocardial perfusion scintigraphy (MPS) provides a highly cost-effective tool for the early detection of obstructive CAD in symptomatic individuals and contributes substantially to stratification of patients according to their risk...
Abstract
Cited 30 times since 2008 (1.7 per year)
source: EuropePMC
Clinical and vaccine immunology : CVI,
Volume 15, Issue 3, 16 3 2008, Pages 522-533
Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH
The stable incidence of new leprosy cases suggests that transmission of infection is continuing despite the worldwide implementation of multidrug therapy programs. Highly specific tools are required to accurately diagnose asymptomatic and early stage Mycobacterium leprae infections which are the likely sources of transmission and cannot be identified by using the detection of antibodies against phenolic glycolipid I. One of the hurdles hampering T-cell-based diagnostic tests is that M. leprae an...
Abstract
Cited 16 times since 2008 (0.9 per year)
source: EuropePMC
Heart (British Cardiac Society),
Volume 95, Issue 2, 15 3 2008, Pages 119-124
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain.
van Ramshorst J, Atsma DE, Beeres SL, Mollema SA, Ajmone Marsan N, Holman ER, van der Wall EE, Schalij MJ, Bax JJ
Objective: To evaluate the effect of bone marrow cell injection on global strain and left ventricular (LV) dyssynchrony. Methods: In 14 patients with severe postinfarction heart failure, 93 (14) x 10(6) autologous bone marrow cells were percutaneously injected in the infarction border zone. LV ejection fraction (LVEF), LV dyssynchrony and echocardiographic global strain were assessed at baseline and 3 months in patients and in a non-randomised control group of 10 patients with a history of infar...
Abstract
Cited 18 times since 2008 (1 per year)
source: EuropePMC
Archives of gerontology and geriatrics,
Volume 48, Issue 1, 4 1 2008, Pages 116-120
Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Feringa HH, Bax JJ, Karagiannis SE, Noordzij P, van Domburg R, Klein J, Poldermans D
This study assesses risk factors in elderly vascular surgery patients and to evaluate whether perioperative cardiac medication can reduce postoperative mortality rate. In a cohort study, 1693 consecutive patients > or =65 years undergoing major non-cardiac vascular surgery were preoperatively screened for cardiac risk factors and medication. During follow-up (median: 8.2 years), mortality was noted. Hospital mortality occurred in 8.1% and long-term mortality in 28.5%. In multivariate analysis...
Abstract
